TCTR20220110001RecruitingPhase 4
The humoral immunogenicity of hepatitis A vaccine series in children after liver transplantation
/A0 sites60 target enrollmentStarted: January 10, 2022Last updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Recruiting
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 Years to 18 Years (—)
- Sex
- All
Inclusion Criteria
- •liver transplanted patients aged less than 18 years old, hepatitis A antibody less than 10 mIU/mL, healthy/no fever at the time of enrollment and underwent liver transplantation for more than 6 months
Exclusion Criteria
- •patients have acute illness, fever BT> 37.8 C or underwent liver transplantation for less than 6 months.
Investigators
Similar Trials
Recruiting
Not Applicable
To evaluate prevalence of Hepatitis A virus in Indian childreCTRI/2011/09/002005Wockhardt Limited1,068
Not yet recruiting
Not Applicable
To find out prior infection of Hepatitis A in non vaccinated adolescents aged 9-12 yearsCTRI/2022/10/046790Department of Pediatrics
Recruiting
Phase 4
Immunogenicity of live attenuated hepatitis A vaccine in overweight and obese children/adolescent/young adultOverweight or obesityHepatitis A vaccine,immunogenicity,overweight,obesityTCTR20191230001BIOGENETECH CO., LTD.200
Completed
Not Applicable
To assess the presence of antibodies against Hepatitis A in children and adults from four cities of India.CTRI/2019/11/022007Bharati Vidyapeeth Deemed to be University Medical College Hospital2,230
Recruiting
Phase 4
How well is the efficacy of hepatitis A vaccination in elderly people?hepatitis A vaccinationjaundice10047438NL-OMON34411Alysis Zorggroep60